Curanex Pharmaceuticals Inc Common Stock

CURXNASDAQ • USD
ThemeBiotech - Drug Development›Metabolic & Cardiometabolic
0.27 USD
↗ 0.00 (1.72%)AT CLOSE (11:59 AM EDT)
0.27
↗ 0.01 (3.20%)
POST MARKET (AS OF 07:55 PM EDT)
Post Market
AS OF 07:55 PM EDT
0.27
↗ 0.01 (3.20%)
🔴Market: CLOSED

Curanex Pharmaceuticals Inc Common Stock (CURX) is currently trading at $0.27. Technical indicators currently signal "Strong Sell". This is driven by negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. Valuation metrics suggest CURX is trading at a discount to its peers, earning an "Attractively Valued" rating.

Technical & fundamental data as of Jun 26, 2026.

Open?$0.29
High?$0.29
Low?$0.27
Prev. Close?$0.26
Volume?50.9K
Avg. Volume?80.4K
VWAP?$0.28
Rel. Volume?0.63x
Bid / Ask
Bid?$0.22 × 100
Ask?$0.31 × 100
Spread?$0.09
Midpoint?$0.27
Valuation & Ratios
Market Cap?7.7M
Shares Out?28.4M
Float?9.1M
Float %?32.2%
P/E Ratio?N/A
P/B Ratio?0.95
EPS?-$0.26
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Curanex Pharmaceuticals Inc is engaged in discovering, developing, and commercializing botanical drugs for treating unmet medical needs in patients with inflammatory disease. Its compound, Phyto-N, is in preclinical research for six indications: ulcerative colitis, atopic dermatitis, COVID-19, type 2 diabetes, nonalcoholic fatty liver disease (NAFLD) and gout. Phyto-N, is a proprietary botanical extract with chemical components and pharmacological activities that harnesses potential anti-inflammatory properties of a medicinal plant.
Themes
Biotech - Drug Development›Metabolic & CardiometabolicBiotech - Drug Development›Immunology & Autoimmune
Employees
6
Market Cap
7.4M
Industry
PHARMACEUTICAL PREPARATIONS
Website
www.curanexpharma.com
Listed
2025-08-26
Address
2 JERICHO PLAZA,
JERICHO, NY 11753
Phone: 718-673-6078
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-3/3)
Medium-Term (Wave)?▼ Bearish(-2/3)
Short-Term (Ripple)?– Neutral(0/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →
Fundamental Outlook
Loading...
Short InterestLow
Short % of Float?0.37%Low
Short Interest?33.6K
Days to Cover?1.0
Free Float9.1M
Avg Daily Volume94.8K
Settlement Date2026-06-15
Financial Health
Current Ratio?62.87Strong
Quick Ratio?62.87Strong
Cash Ratio?31.22Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
100/100
P/E?
N/A▾
P/B?
Peers
100
S&P
97
0.95CHEAP▾
P/S?
N/A▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-0.5CHEAP▾
EV/Sales?
N/A▾
Returns & Efficiency
ROE?
S&P
3
-89.6%WEAK▾
ROA?
S&P
3
-86.1%WEAK▾
Cash Flow & Enterprise
FCF?N/A
Enterprise Value?$3.6M
Fundamentals ratios updated end of day
MarketsMoversWatchlist